High-Dimensional Immunophenotyping of Plasma-Derived Small Extracellular Vesicles in Pancreatic Cancer: An...

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Pancreatic ductal adenocarcinoma (PDAC) is a systemic malignancy with complex tumor-host interactions.
• Small extracellular vesicles (sEVs) in blood may reflect these systemic changes and serve as diagnostic biomarkers.
• Current diagnostic methods for PDAC often lack sensitivity and specificity.

Purpose of the Study:

• To investigate the potential of plasma-derived sEVs as a source of biomarkers for PDAC.
• To characterize the surface immunophenotype of sEVs in PDAC patients compared to healthy controls and neuroendocrine lung cancer (NLC) patients.
• To explore the feasibility of using sEVs for disease-specific marker pattern identification.

Main Methods:

• Isolation of plasma sEVs using differential ultracentrifugation.
• Characterization of sEVs via western blotting and nanoparticle tracking analysis.
• Surface marker profiling using MACSPlex EV Kit IO, followed by statistical and machine-learning analyses.

Main Results:

• PDAC-derived sEVs exhibited a unique immunophenotype with enriched angiogenesis (CD105, CD146), immune-regulatory (CD25, CD40), coagulation (CD142), and invasion (MCSP) markers.
• Machine learning models demonstrated exploratory separation of PDAC patients from healthy controls and NLC patients based on sEV surface markers.
• Longitudinal analysis in a small subset showed measurable changes in sEV markers during chemotherapy.

Conclusions:

• Plasma sEV immunophenotyping is a feasible method for detecting systemic alterations in PDAC.
• Distinct sEV surface marker patterns hold promise for developing PDAC-specific biomarkers.
• This study provides a foundation for future validation studies focused on PDAC biomarker discovery.